CSX Corp is not a strong buy for a beginner, long-term investor at this time. While the company has positive long-term prospects, the recent price decline, weak financial performance, and hedge fund selling suggest caution. The investor should wait for better entry points or clearer signs of recovery.
The stock is showing bearish momentum with a negatively expanding MACD histogram (-0.162) and an RSI of 33.347, which is approaching oversold territory but not yet signaling a reversal. The stock is trading below its pivot level of 42.192, with key support at 41.23 and 40.635. Moving averages (SMA_5 > SMA_20 > SMA_200) remain bullish, but the recent price action suggests weakness.

Analysts have raised price targets recently, with Jefferies increasing the target to $50, citing strong dividend growth and a unique market position.
The company announced an 8% dividend increase, reflecting shareholder confidence.
Hedge funds are heavily selling, with a 6358.05% increase in selling activity last quarter.
Weak Q4 financial performance, including a YoY revenue decline of -0.88% and net income drop of -1.77%.
The stock has a bearish short-term trend, with a projected -3.52% decline over the next month.
In Q4 2025, CSX reported a revenue decline of -0.88% YoY to $3.51 billion and a net income drop of -1.77% YoY to $720 million. EPS increased by 2.63% YoY to 0.39, but gross margin fell to 58.01%, down -1.96% YoY. Overall, the financial performance indicates stagnation and declining profitability.
Analysts are generally positive, with multiple firms raising price targets recently. Jefferies raised the target to $50, citing the company's strong infrastructure position and low obsolescence risk. However, some firms, like Bernstein, have downgraded their outlook due to weak revenue and earnings performance. The consensus is cautiously optimistic, with a mix of Buy and Neutral ratings.